The frequencies of CYP2D6 mutations in a Japanese population were investiga
ted. Individuals were classified into three groups: control individuals, ca
ncer patients and Parkinsonians, Genotyping for CYP2D6*3, CYP2D6*4 and CYP2
D6*18 was carried out using the polymerase chain reaction, and that for CYP
2D6*5 was also carried out using XbaI restriction fragment length polymorph
ism. The frequencies of the CYP2D6*3, CYP2D6*4, CYP2D6*5 and CYP2D6*18 muta
nt alleles were 0%, 0.77%, 4.10% and 0.53% in more than 256 Japanese contro
l individuals, respectively. Based on these data, the population frequency
of the CYP2D6 poor metabolizer phenotype was estimated to be 0.29%. The dis
tribution of the four mutated alleles was not significantly different betwe
en control individuals and cancer patients or Parkinsonians. Pharmacogeneti
cs 9:601-605 (C) 1999 Lippincott Williams & Wilkins.